Clinical trial · Observational
Survival Outcomes in Metastatic Prostate Cancer in the Brazilian Population - Analysis of Individual Characteristics and Treatment Modalities in Different National Health Institutions.
NCT04962919CI-TRIAL-00125247LACOG 1818completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Survival outcomes in metastatic prostate cancer in the population Brazilian - analysis of individual characteristics and modalities of treatment in different national health institutions
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Prostatic Neoplasms, Castration-Resistant | Prostate Neoplasm | ALIAS | 0.85 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (2)
- label
- Public institution
- description
- Castration-resistant metastatic prostate cancer diagnosed between January 2014 and December 2017
- label
- Private institution
- description
- Castration-resistant metastatic prostate cancer diagnosed between January 2014 and December 2017
Primary outcomes (1)
- measure
- Describe cause-specific survival in patients with castration-resistant prostate cancer in different institutions in Brazil.
- timeFrame
- December of 2017
Secondary outcomes (9)
- measure
- To describe the sociodemographic characteristics of patients with castration-resistant metastatic prostate cancer in Brazil;
- timeFrame
- December of 2017
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Diagnosis of castration-resistant metastatic prostate cancer diagnosed in the period between January 2014 and December 2017. Exclusion Criteria: * Diagnosis of localized or locally advanced or metastatic disease sensitive to castration; * Patients with medical records filled with incomplete data that make it impossible to evaluate the treatment received.
References
Publications (0)
Data not yet available
No reference posted for this study.